PCDH9 and cholangiocarcinoma: For example, we should prepare the rats with specifically PCDH9 knockout in the bile duct, and then TAA-induced pre-CCA animal will be applied to test whether PCDH9 depletion in the bile duct would block CCA occurrence and progression.